Status:
UNKNOWN
The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe
Lead Sponsor:
Andreas L. Serra
Conditions:
Autosomal Dominant Polycystic Kidney Disease
Eligibility:
All Genders
18+ years
Brief Summary
EuroCYST initiative aims to build a large, well-characterized cohort of Autosomal Dominant polyCYSTic Kidney Disease (ADPKD) subjects who are followed in a longitudinal observational cohort study has ...
Detailed Description
The EuroCYST Initiative aims to build a network of ADPKD reference centers across Europe and to establish a large-scale observational cohort of ADPKD patients for the purpose of studying the pathogene...
Eligibility Criteria
Inclusion
- Participants ≥ 18 years;
- Clinical diagnosis of ADPKD based on kidney imaging and family history;
- Estimated Glomerular Filtration Rate (eGFR) ≥ 30 ml/min/1.73m2 (Chronic Kidney Disease Epidemiology Collaboration(CKD-EPI)- formula);
- Provided written informed consent.
Exclusion
- Receiving chronic renal replacement therapy before enrollment (dialysis, allograft) or anticipated in the following 12 months after enrollment;
- Participation in a clinical trial aiming to modify disease outcome one year or less before enrollment in the EuroCYST study;
- New York Heart Association (NYHA) stadium IV.
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT02187432
Start Date
August 1 2013
End Date
December 1 2016
Last Update
May 27 2015
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques universitaires Saint-Luc
Brussels, Belgium, 1200
2
Charles University Prague
Prague, Czechia, 128 08
3
Centre hospitalier universitaire de Brest
Brest, France, 29609
4
Hôpital de Rangueil
Toulouse, France, 31059